Metalloproteinases are enriched in microglia compared with leukocytes and they regulate cytokine levels in activated

Robert K Nuttall1, Claudia Silva, Walter Hader

  • 1School of Biological Sciences, University of East Anglia, Norwich, United Kingdom.

Glia
|January 12, 2007
PubMed

Insights

Microglia, the brain's immune cells, express unique metalloproteinases (MMPs and ADAMs) compared to other immune cells. Activated microglia increase specific MMPs and decrease TIMP3, contributing to neuroinflammation and TNF-alpha secretion.

Area of Science:

  • Neuroimmunology
  • Protease biology

Background:

  • Microglia are key immune cells in the central nervous system (CNS).
  • Neurological injuries activate microglia, increasing cytokine and protease expression.
  • The specific metalloproteinases (MMPs, ADAMs) and their inhibitors (TIMPs) in microglia and infiltrating leukocytes are not fully characterized.

Purpose of the Study:

  • To determine the expression profile of all known metalloproteinases and their inhibitors in human microglia and various systemic immune cells.
  • To investigate how microglial activation affects the expression of these proteases and their inhibitors.
  • To elucidate the role of metalloproteinases in the secretion of inflammatory cytokines, particularly TNF-alpha, by activated microglia.

Main Methods:

  • Quantitative analysis of transcripts for 24 MMPs, 9 ADAMs, and 4 TIMPs in isolated human microglia, B cells, T cells, monocytes, and neutrophils.
  • Assessment of microglial activation markers, including cytokine protein levels (TNF-alpha, IL-1beta, IL-10) in cell culture.
  • Inhibition studies using a metalloproteinase inhibitor (BB94) and specific TIMPs to assess their effect on cytokine secretion.

Main Results:

  • Microglia exhibit a distinct metalloproteinase expression pattern compared to peripheral leukocytes, with higher overall metalloproteinase enrichment.
  • Microglial activation led to upregulation of transcripts for nine metalloproteinases and downregulation of TIMP3.
  • Activated microglia secreted increased levels of TNF-alpha, IL-1beta, and IL-10; TNF-alpha secretion was partially inhibited by a metalloproteinase inhibitor and TIMP3, suggesting involvement of an ADAM member.

Conclusions:

  • Microglia possess a unique metalloproteinase signature distinct from systemic immune cells.
  • Activated microglia enhance TNF-alpha secretion via increased cytokine transcripts, elevated metalloproteinase activity, and reduced TIMP3 levels.
  • These findings offer insights into the regulation of neuroinflammation and its consequences in CNS injuries.